<DOC>
	<DOCNO>NCT02329366</DOCNO>
	<brief_summary>This project aim result identification marker , development feasible quantitative method distinguish tissue capacity heal tissue , thus identify non-healing phenotype .</brief_summary>
	<brief_title>Development Cellular Biomarker Diagnosis Treatment Diabetic Foot Ulcers</brief_title>
	<detailed_description>The goal project identify objective , quantitative biological molecular marker correlate heal outcome diabetic foot ulcer ( DFUs ) use debrided tissue patient wound . This project aim result identification marker , development feasible quantitative method distinguish tissue capacity heal tissue , thus identify non-healing phenotype . The ability differentiate heal non-healing tissue onset wound care allow use target therapy earlier initiation aggressive treatment indicate .</detailed_description>
	<mesh_term>Diabetic Foot</mesh_term>
	<mesh_term>Foot Ulcer</mesh_term>
	<criteria>Male female , age ≥ 18 Type 2 Diabetes A break skin foot ≥ 0.5cm2 Grade 1 2 define Wagner grade system Hemoglobin A1c ≥ 5.9 % Ability provide write informed consent Any experimental drug take orally topically within 4 week study entry Malignant disease at/or proximity DFU Target wind malignant origin Failure satisfy least one inclusion criterion one two study group .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>